Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?

The prototype cysteinyl leukotriene receptor antagonist, montelukast, is generally considered to have a niche application in the therapy of exercise- and aspirin-induced asthma. It is also used as add-on therapy in patients whose asthma is poorly controlled with inhaled corticosteroid monotherapy, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tintinger, Gregory R., Feldman, Charles, Theron, Annette J., Anderson, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2010
Materias:
Mini-Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763941/
https://www.ncbi.nlm.nih.gov/pubmed/21170491
http://dx.doi.org/10.1100/tsw.2010.229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763941/
https://www.ncbi.nlm.nih.gov/pubmed/21170491
http://dx.doi.org/10.1100/tsw.2010.229

Ejemplares similares